Lilly vs Pfizer: Obesity Race Reaches Market Highs
Lilly leads the GLP-1 obesity wave as Pfizer rebuilds with deals and repurposed assets. Q1 2026 results underscore tw...
Learn how to choose a low-fee Dividend Aristocrats ETF and what fees to watch. This intro covers cost factors and quick tips for a cost-efficient selection.
24,603 articlesLilly leads the GLP-1 obesity wave as Pfizer rebuilds with deals and repurposed assets. Q1 2026 results underscore tw...
Snap aims to redefine how we interact with the world through AR glasses, but can this gadget lift the stock? This gui...
The eVTOL craze mixes hype with real engineering, regulatory hurdles, and capital burn. Here's why I wouldn't touch t...
As of mid-2026, the U.S. housing market remains tight. Boomers hold many homes and aren’t selling fast, while Millenn...
A private liberal arts college in the Pacific Northwest launches a four-year tuition cap set at 10% of a family’s inc...
As housing costs stretch budgets, industry observers turn to the ROAD to Housing Act for relief. BOK Financial’s Mich...
Tower Semiconductor faced a notable drop as AI-driven demand and profitability questions swirl. This guide breaks dow...
Savara investors should stay focused on how insider moves and regulatory timelines interact with a growing biotech st...
The space economy is expanding faster than many investors realize. This space stock could ride the wave, driven by sm...
A 63-year-old couple converting $90,000 to a Roth in 2026 could face higher Medicare premiums in 2028 due to the IRMA...
Former President Trump disclosed soaring digital-asset holdings, including hundreds of millions from meme-token sales...
When a sports contract becomes a financial puzzle, you learn what to watch for in any investment. This piece breaks d...